Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVALGLUCOSIDASE ALFA-NGPT: 741 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
741
Total FAERS Reports
3 (0.4%)
Deaths Reported
74
Hospitalizations
741
As Primary/Secondary Suspect
5
Life-Threatening
6
Disabilities
Prescription
Status

FDA Application: 761194 ·

First Report: 20201019 · Latest Report: 20250910

What Are the Most Common AVALGLUCOSIDASE ALFA-NGPT Side Effects?

#1 Most Reported
Drug specific antibody present
124 reports (16.7%)
#2 Most Reported
Off label use
76 reports (10.3%)
#3 Most Reported
Weight increased
41 reports (5.5%)

All AVALGLUCOSIDASE ALFA-NGPT Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug specific antibody present 124 16.7% 0 0
Off label use 76 10.3% 0 2
Weight increased 41 5.5% 0 5
Weight decreased 34 4.6% 0 8
Inappropriate schedule of product administration 30 4.1% 0 6
Fatigue 28 3.8% 0 2
Dyspnoea 25 3.4% 0 3
Pyrexia 25 3.4% 0 6
Illness 23 3.1% 0 2
Headache 22 3.0% 0 3
Condition aggravated 21 2.8% 0 5
Product preparation error 20 2.7% 0 0
Pruritus 20 2.7% 0 2
Covid-19 19 2.6% 0 4
Malaise 18 2.4% 0 3
Pneumonia 17 2.3% 1 9
Rash 16 2.2% 0 1
Cough 15 2.0% 1 0
Fall 15 2.0% 1 4
Hypertension 15 2.0% 0 1

Who Reports AVALGLUCOSIDASE ALFA-NGPT Side Effects? Age & Gender Data

Gender: 54.5% female, 45.5% male. Average age: 38.0 years. Most reports from: US. View detailed demographics →

Is AVALGLUCOSIDASE ALFA-NGPT Getting Safer? Reports by Year

YearReportsDeathsHosp.
2020 1 0 0
2021 8 0 0
2022 82 0 14
2023 127 0 12
2024 118 1 17
2025 79 0 10

View full timeline →

What Is AVALGLUCOSIDASE ALFA-NGPT Used For?

IndicationReports
Glycogen storage disease type ii 471
Product used for unknown indication 12

AVALGLUCOSIDASE ALFA-NGPT vs Alternatives: Which Is Safer?

AVALGLUCOSIDASE ALFA-NGPT vs AVANAFIL AVALGLUCOSIDASE ALFA-NGPT vs AVANDAMET AVALGLUCOSIDASE ALFA-NGPT vs AVANDIA AVALGLUCOSIDASE ALFA-NGPT vs AVAPRITINIB AVALGLUCOSIDASE ALFA-NGPT vs AVASTIN AVALGLUCOSIDASE ALFA-NGPT vs AVATROMBOPAG AVALGLUCOSIDASE ALFA-NGPT vs AVELOX AVALGLUCOSIDASE ALFA-NGPT vs AVELUMAB AVALGLUCOSIDASE ALFA-NGPT vs AVIBACTAM AVALGLUCOSIDASE ALFA-NGPT vs AVIBACTAM\CEFTAZIDIME

Official FDA Label for AVALGLUCOSIDASE ALFA-NGPT

Official prescribing information from the FDA-approved drug label.